Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NCOR2 antisense RNA 1 (NCOR2-AS1)
- Target
- NCOR2-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
NCOR2 antisense RNA 1 (NCOR2-AS1) is a long non-coding antisense RNA gene located on the opposite strand of the NCOR2 protein-coding locus. Antisense lncRNAs commonly regulate the expression or alternative splicing of their associated sense gene through direct RNA-RNA interactions or modulation of chromatin architecture. While general mechanisms of antisense RNAs are increasingly understood—including their potential effects on gene regulation, splicing, and chromatin state—the specific function and clinical relevance of NCOR2-AS1 remain undefined. It has not been linked to any disease, clinical biomarker, or drug interaction, and is not considered a therapeutic target or receptor.
- Other names
- NCOR2-AS1LOC105370047
02
Mechanism of action
None described for drugs targeting this molecule.
03
Biological functions
May regulate alternative splicing and gene expression through RNA-RNA interactions with the parent NCOR2 gene pre-mRNA, as described for other antisense lncRNAsGeneral roles for antisense lncRNAs include modulation of transcription, interfering with RNA polymerase binding, and influencing chromatin structureSpecific functional details for NCOR2-AS1 are currently unavailable.
04
Disease associations
No direct disease association has been documented for NCOR2-AS1 in the literature or curated databases.Other NCOR2 regulatory mechanisms (such as alternate splicing by lncRNAs) have implications for cancer proliferation and progression, but NCOR2-AS1's involvement has not been established.
Beyond the preview
Go deeper on NCOR2 antisense RNA 1 (NCOR2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NCOR2 antisense RNA 1 (NCOR2-AS1).